作者: Kennett Sprogøe , Thomas Wegge , Silvia Kaden-Vagt , Harald Rau , Torben Lessmann
DOI:
关键词:
摘要: The present invention relates to a pharmaceutical composition comprising an insulin compound in concentration that is sufficient maintain therapeutically effective level of the blood plasma for at least 3 days characterized by having pharmacokinetic profile vivo with substantially no burst compound. further use preparing said as well kit parts composition.